By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

GammaCan International, Inc. 



Givat Shmuel      Israel
Phone: 972-3-53-24-101 Fax:


SEARCH JOBS








Company News
GammaCan International, Inc. (GCAN.OB) Release: VitiGam(TM) Inhibits Melanoma Growth in a Dose Dependent Manner 8/11/2008 8:19:16 AM
GammaCan International, Inc. (GCAN.OB) Executes Supply Agreement with Bio Products Laboratory to Manufacture VitiGam(TM) for the Treatment of Melanoma for Clinical Testing and Commercial Sale 6/4/2008 8:20:48 AM
GammaCan International, Inc. (GCAN.OB) Announces Positive Testing Results in the Development of VitiGam(TM) for the Treatment of Melanoma 3/6/2008 11:34:24 AM
GammaCan International, Inc. (GCAN.OB) to Present at the Rodman & Renshaw 9th Annual Healthcare Conference 2007 11/5/2007 9:46:32 AM
GammaCan International, Inc. (GCAN.OB) Enters into Vitiligo Plasma Supply Agreement with DCI Biologicals 10/1/2007 9:45:23 AM
Taglich Brothers Initiates Coverage on GammaCan International, Inc. (GCAN.OB) 9/21/2007 8:32:44 AM
GammaCan International, Inc. (GCAN.OB) Receives FDA Orphan Drug Designation for Lead Product VitiGam(TM) for Stage IIB to Stage IV Melanoma 8/7/2007 1:05:31 PM
GammaCan International, Inc. (GCAN.OB) Discovers Anti-Angiogenic Properties in Plasma-Derived IgG; Company Files Patent Application Pertaining to Disorders of Neovascularization Including Cancer and Other Diseases 6/28/2007 1:11:29 PM
GammaCan International, Inc. (GCAN.OB) Retains Investor Relations Firm ROI Group 6/27/2007 1:31:33 PM
GammaCan International, Inc. (GCAN.OB) to Present and Webcast at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference 5/14/2007 12:09:12 PM
12345
//-->